Literature DB >> 8994863

Epitope spreading.

C J Vanderlugt1, S D Miller.   

Abstract

Epitope (determinant) spreading is the development of immune responses to endogenous epitopes secondary to the release of self antigens during a chronic autoimmune or inflammatory response. The past year has seen considerable advances in our understanding of the contribution of epitope spreading to the chronic pathogenesis of experimental T-cell-mediated and antibody-mediated autoimmune diseases. Most significantly, conclusive functional evidence for a major role for epitope spreading in the chronic pathogenesis of murine relapsing-remitting experimental autoimmune encephalomyelitis, a CD4+ T-cell-mediated model of multiple sclerosis, was forthcoming.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8994863      PMCID: PMC7135770          DOI: 10.1016/s0952-7915(96)80012-4

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  34 in total

Review 1.  Determinant spreading and the dynamics of the autoimmune T-cell repertoire.

Authors:  P V Lehmann; E E Sercarz; T Forsthuber; C M Dayan; G Gammon
Journal:  Immunol Today       Date:  1993-05

Review 2.  Superantigens: bacterial and viral proteins that manipulate the immune system.

Authors:  M T Scherer; L Ignatowicz; G M Winslow; J W Kappler; P Marrack
Journal:  Annu Rev Cell Biol       Date:  1993

3.  Reversal of acute experimental autoimmune encephalomyelitis and prevention of relapses by treatment with a myelin basic protein peptide analogue modified to form long-lived peptide-MHC complexes.

Authors:  M F Samson; D E Smilek
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

Review 4.  Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating diseases.

Authors:  S D Miller; B L McRae; C L Vanderlugt; K M Nikcevich; J G Pope; L Pope; W J Karpus
Journal:  Immunol Rev       Date:  1995-04       Impact factor: 12.988

5.  Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen.

Authors:  P V Lehmann; T Forsthuber; A Miller; E E Sercarz
Journal:  Nature       Date:  1992-07-09       Impact factor: 49.962

6.  Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease.

Authors:  J H Vaughan; M D Nguyen; J R Valbracht; K Patrick; G H Rhodes
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

7.  Kinetics and specificity of T and B cell responses in relapsing experimental allergic encephalomyelitis.

Authors:  L L Perry; M E Barzaga
Journal:  J Immunol       Date:  1987-03-01       Impact factor: 5.422

8.  Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes.

Authors:  J Tian; M A Atkinson; M Clare-Salzler; A Herschenfeld; T Forsthuber; P V Lehmann; D L Kaufman
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

9.  A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease.

Authors:  M Yu; J M Johnson; V K Tuohy
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

10.  Characterization of measles virus-induced cellular autoimmune reactions against myelin basic protein in Lewis rats.

Authors:  U G Liebert; G A Hashim; V ter Meulen
Journal:  J Neuroimmunol       Date:  1990 Sep-Oct       Impact factor: 3.478

View more
  68 in total

1.  Autoantibodies to type VII collagen have heterogeneous subclass and light chain compositions and their complement-activating capacities do not correlate with the inflammatory clinical phenotype.

Authors:  K Gandhi; M Chen; S Aasi; J C Lapiere; D T Woodley; L S Chan
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

Review 2.  The origin and regulation of autopathogenic T cells.

Authors:  A C Anderson; L B Nicholson; V K Kuchroo
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

Review 3.  Defining the parameters necessary for T-cell recognition of ligands that vary in potency.

Authors:  Neely E Kilgore; Mandy L Ford; Carrie D Margot; Daniel S Jones; Peter Reichardt; Brian D Evavold
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 4.  Have we overestimated the benefit of human(ized) antibodies?

Authors:  Daniel R Getts; Meghann T Getts; Derrick P McCarthy; Emily M L Chastain; Stephen D Miller
Journal:  MAbs       Date:  2010-11-01       Impact factor: 5.857

5.  Spreading of antibody reactivity to non-thyroid antigens during experimental immunization with human thyroglobulin.

Authors:  A Thrasyvoulides; E Liakata; P Lymberi
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

Review 6.  Recent advances in the understanding of celiac disease: therapeutic implications for the management of pediatric patients.

Authors:  John H Kwon; Richard J Farrell
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 7.  Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

Authors:  Robert S Fujinami; Matthias G von Herrath; Urs Christen; J Lindsay Whitton
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 8.  Glioblastoma antigen discovery--foundations for immunotherapy.

Authors:  Tej D Azad; Seyed-Mostafa Razavi; Benjamin Jin; Karen Lee; Gordon Li
Journal:  J Neurooncol       Date:  2015-06-05       Impact factor: 4.130

9.  Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.

Authors:  Katarina Tengvall; Jesse Huang; Cecilia Hellström; Patrick Kammer; Martin Biström; Burcu Ayoglu; Izaura Lima Bomfim; Pernilla Stridh; Julia Butt; Nicole Brenner; Angelika Michel; Karin Lundberg; Leonid Padyukov; Ingrid E Lundberg; Elisabet Svenungsson; Ingemar Ernberg; Sigurgeir Olafsson; Alexander T Dilthey; Jan Hillert; Lars Alfredsson; Peter Sundström; Peter Nilsson; Tim Waterboer; Tomas Olsson; Ingrid Kockum
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-02       Impact factor: 11.205

Review 10.  Autoimmunity, immunodeficiency and mucosal infections: chronic intestinal inflammation as a sensitive indicator of immunoregulatory defects in response to normal luminal microflora.

Authors:  H Tlaskalová-Hogenová; R Stĕpánková; L Tucková; M A Farré; D P Funda; E F Verdú; J Sinkora; T Hudcovic; Z Reháková; B Cukrowska; H Kozáková; L Prokesová
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.